Rule 107. (1) A licensee shall obtain consent for treatment before providing a
telehealth service under section 16284 of the code, MCL 333.16284.
(2) A licensee shall maintain proof of consent for telehealth treatment in the
patient’s up-to-date medical record and satisfy section 16213 of the code, MCL
333.16213.
(3) A licensee providing a telehealth service may prescribe a drug if the licensee
is a prescriber acting within the scope of the licensee’s practice and in compliance
with section 16285 of the code, MCL 333.16285, and if the licensee does both of
the following:
(a) Refers the patient to a provider who is geographically accessible to the
patient, if medically necessary.
(b) Makes the licensee available to provide follow-up care services to the patient,
or to refer the patient to another provider, for follow-up care.
(4) A licensee providing any telehealth service shall do both of the following:
(a) Act within the scope of the licensee’s practice.
(b) Exercise the same standard of care applicable to a traditional, in-person
healthcare service.
History: 2021 AACS; 2023 AACS; 2024 AACS.
R 338.2409 Prescribing of drugs by physician’s assistants; procedures and
protocols.
Rule 109. (1) Under sections 17048(2) and 17076(2) of the code, MCL
333.17048 and 333.17076, and under the terms of a practice agreement, a
physician’s assistant may prescribe a drug, including a controlled substance that
is included in schedules 2 to 5 of part 72 of the code, MCL 333.7201 to 333.7231,
subject to both of the following requirements:
(a) If a physician's assistant prescribes a drug, the physician's assistant's name
must be used, recorded, or otherwise indicated in connection with that prescription.
(b) If a physician's assistant prescribes a drug that is included in schedules 2 to
5, the physician's assistant's Drug Enforcement Agency (DEA) registration number
must be used, recorded, or otherwise indicated in connection with that prescription.
(2) Under sections 17048(2) and 17076(3) of the code, MCL 333.17048 and
333.17076, and under the terms of a practice agreement, a physician's assistant
may order, receive, and dispense complimentary starter dose drugs, including
controlled substances that are included in schedules 2 to 5 of part 72 of the code,
MCL 333.7201 to 333.7231, subject to both of the following requirements:
(a) If a physician's assistant orders, receives, or dispenses a complimentary
starter dose drug, the physician's assistant's name must be used, recorded, or
otherwise indicated in connection with that order, receipt, or dispensing.
(b) If a physician's assistant orders, receives, or dispenses a complimentary
starter dose drug that is included in schedules 2 to 5, the physician's assistant's
DEA registration number must be used, recorded, or otherwise indicated in
connection with that order, receipt, or dispensing.
History: 2016 AACS; 2021 AACS.
Page 2